MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on August 22, 2007; DOI: 10.1124/mol.107.039446


This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
mol.107.039446v1
72/5/1210    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yoon, E.-J.
Right arrow Articles by Hamm, H. E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yoon, E.-J.
Right arrow Articles by Hamm, H. E


Received for publication June 28, 2007.
Revised August 17, 2007.
Accepted for publication August 22, 2007.

G{beta}{gamma} interferes with Ca2+-dependent binding of synaptotagmin to the SNARE complex

Eun-Ja Yoon 1, Tatyana Gerachshenko 2, Bryan D Spiegelberg 1, Simon Alford 2, Heidi E Hamm 1*

1 Vanderbilt University 2 University of Illinois at Chicago

* Address correspondence to: E-mail: heidi.hamm{at}vanderbilt.edu

Abstract

Presynaptic inhibitory GPCRs can decrease neurotransmission by inducing interaction of G{beta}{gamma} with the soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) complex. Previously, we showed that this action of G{beta}{gamma} requires the carboxyl terminus of SNAP25 and is downstream of the well-known inhibition of Ca2+ entry through voltage-gated calcium channels (VGCC). We proposed a mechanism in which G{beta}{gamma} and synaptotagmin compete for binding to the SNARE complex. Here, we characterized the G{beta}{gamma} interaction sites on syntaxin1A and SNAP25 and demonstrated an overlap of the G{beta}{gamma}- and synaptotagmin I -binding regions on each member of the SNARE complex. Synaptotagmin competes in a Ca2+-sensitive manner with binding of G{beta}{gamma} to SNAP25, syntaxin1A and the assembled SNARE complex. We predict based on these findings that at high intracellular Ca2+ concentrations, Ca2+-synaptotagmin I can displace G{beta}{gamma} binding, and the G{beta}{gamma}-dependent inhibiton of exocytosis can be blocked. We tested this hypothesis in giant synapses of the lamprey spinal cord, where 5-HT works via G{beta}{gamma} to inhibit neurotransmission (Blackmer et al., 2001). We showed that increased presynaptic Ca2+ suppresses the 5-HT- and G{beta}{gamma}-dependent inhibition of exocytosis. We suggest that this effect may be due to Ca2+-dependent competition between G{beta}{gamma} and synaptotagmin I for SNARE binding. This type of dynamic regulation may represent a novel mechanism for modifying transmitter release in a graded manner based on the history of action potentials that increase intracellular Ca2+ concentrations and of inhibitory signals through Gi-coupled GPCRs.


Key words: Gi family, G protein regulation, Exocytosis


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
E. M. Silinsky
Selective disruption of the mammalian secretory apparatus enhances or eliminates calcium current modulation in nerve endings
PNAS, April 29, 2008; 105(17): 6427 - 6432.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics